↓ Skip to main content

Dove Medical Press

Article Metrics

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2010
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
37 Mendeley
Title
Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
Published in
Neuropsychiatric Disease and Treatment, December 2010
DOI 10.2147/ndt.s15911
Pubmed ID
Authors

Rogelio Apiquian, Rodrigo Cordoba, M R Louza

Abstract

Risperidone long-acting injection (RLAI) has been shown to be efficacious, improve compliance, and increase long-term retention rate on therapy. The aim of this work was to determine the effect of RLAI on clinical outcome and hospitalization rate in patients with schizophrenia or schizoaffective disorder enrolled in the electronic Schizophrenia Treatment Adherence Registry in Latin America.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Brazil 1 3%
Unknown 35 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 22%
Student > Master 7 19%
Student > Ph. D. Student 6 16%
Other 3 8%
Student > Bachelor 3 8%
Other 7 19%
Unknown 3 8%
Readers by discipline Count As %
Medicine and Dentistry 14 38%
Psychology 6 16%
Economics, Econometrics and Finance 3 8%
Neuroscience 2 5%
Nursing and Health Professions 2 5%
Other 4 11%
Unknown 6 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2011.
All research outputs
#2,016,276
of 3,629,283 outputs
Outputs from Neuropsychiatric Disease and Treatment
#466
of 677 outputs
Outputs of similar age
#33,975
of 72,148 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#21
of 31 outputs
Altmetric has tracked 3,629,283 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 677 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,148 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.